间充质干细胞联合前体药物基因疗法治疗转移性头颈癌
Treatment of metastatic head and neck cancer with mesenchymal stem cells combined with prodrug gene therapy.
作者信息
Lakota J, Gocarova K, Spanik S
机构信息
Laboratory of Molecular Oncology, Cancer Research Institute, Slovak Academy of Sciences, Bratislava 83391, Slovakia.
Department of Medical Oncology, St. Elizabeth Cancer Institute, Bratislava 81250, Slovakia.
出版信息
Exp Oncol. 2015 Dec;37(4):298.
PMID:26710845
Abstract
This is a clinical observation of a patient treated for metastatic head and neck cancer with mesenchymal stem cells mediated prodrug gene therapy. The cells were applied intravenously. We did not observe any therapeutic effect. However, a temporal bicytopenia was observed.
摘要
这是一项关于一名接受间充质干细胞介导的前体药物基因疗法治疗转移性头颈癌患者的临床观察。细胞通过静脉注射给药。我们未观察到任何治疗效果。然而，观察到了短暂的双血细胞减少。
Zotero 插件